Quote:
Originally Posted by Altavia
That's like saying, if they did crash testing on blue cars, you don't know how red cars will perform...
Safety and efficacy did not change significantly from the initial vaccine Phase I trials of 30 and then 300 people over two years ago. Nor in the 35,000 enrolled in Phase Iii trials. For both companies.
Same results for other varients recently tested in humans.
They changed the formulation match the currently active varients. Same as for flu vaccine.
|
Thank you for posting, hoping you will change some minds